BRAIN Biotech AG (ETR:BNN)
Germany
· Delayed Price · Currency is EUR 2.290
-0.050 (-2.14%)
Mar 9, 2026, 5:35 PM CET
BRAIN Biotech AG Cash Flow Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 - 2016 |
| Net Income | -10.62 | -11.74 | -11.13 | -8.28 | -6.59 | -4.97 | Upgrade
|
| Depreciation & Amortization | 5.12 | 5.13 | 4.82 | 4.65 | 4.34 | 4.01 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.05 | 0.05 | -0 | -0 | -0.03 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | -0.53 | -2.36 | -0.58 | Upgrade
|
| Loss (Gain) on Equity Investments | 0.53 | 0.53 | 0.5 | 1.49 | 2.43 | 1.72 | Upgrade
|
| Stock-Based Compensation | 0.78 | 0.78 | 0.89 | 0.8 | 0.75 | 0.51 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 0 | -0.02 | 0 | -0 | Upgrade
|
| Other Operating Activities | 0.73 | 0.57 | -4.11 | -2.47 | -3.66 | -5.96 | Upgrade
|
| Change in Accounts Receivable | -0.89 | -0.89 | 1.8 | -1.33 | -0.23 | -0.14 | Upgrade
|
| Change in Inventory | 0.36 | 0.36 | 0.41 | -0.04 | -2.41 | -0.02 | Upgrade
|
| Change in Accounts Payable | -1.23 | -1.23 | -0.11 | -1.17 | 2.53 | 0.31 | Upgrade
|
| Change in Unearned Revenue | 0.47 | 0.47 | 2.36 | 3.49 | 2.51 | 1.72 | Upgrade
|
| Change in Other Net Operating Assets | -3.32 | -3.32 | 1.11 | -0.62 | 1.24 | -0.4 | Upgrade
|
| Operating Cash Flow | -7.96 | -9.23 | -3.58 | -4.22 | -1.49 | -3.91 | Upgrade
|
| Capital Expenditures | -1.53 | -1.53 | -1.55 | -2.62 | -5.8 | -1.25 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.04 | 0.04 | 0.02 | 0.18 | 0.14 | 0 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -3.1 | -0.44 | Upgrade
|
| Divestitures | - | - | - | 3.04 | -1.07 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.07 | -0.07 | -0.18 | -0.02 | -0.28 | -0.01 | Upgrade
|
| Investment in Securities | - | - | - | -0.11 | -1.17 | -0.56 | Upgrade
|
| Other Investing Activities | -0.34 | 0.01 | 0.02 | 0.09 | -1.4 | 0.08 | Upgrade
|
| Investing Cash Flow | -1.91 | -1.56 | -1.69 | 0.56 | -12.69 | -2.18 | Upgrade
|
| Long-Term Debt Issued | - | 0.13 | 31.87 | 13 | 0.35 | 0.06 | Upgrade
|
| Long-Term Debt Repaid | - | -8.57 | -5.48 | -2.96 | -2.32 | -2.88 | Upgrade
|
| Net Debt Issued (Repaid) | -8.44 | -8.44 | 26.39 | 10.05 | -1.97 | -2.82 | Upgrade
|
| Issuance of Common Stock | - | - | 0.6 | - | - | 18.98 | Upgrade
|
| Other Financing Activities | 5.78 | -1.7 | - | -9.59 | - | -4.59 | Upgrade
|
| Financing Cash Flow | -2.66 | -10.14 | 26.99 | 0.46 | -1.97 | 11.57 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.05 | -0.05 | 0.1 | 0.11 | 0.04 | 0.12 | Upgrade
|
| Net Cash Flow | -12.58 | -20.98 | 21.82 | -3.09 | -16.1 | 5.6 | Upgrade
|
| Free Cash Flow | -9.49 | -10.77 | -5.14 | -6.84 | -7.29 | -5.16 | Upgrade
|
| Free Cash Flow Margin | -19.36% | -21.44% | -9.25% | -12.16% | -14.49% | -13.15% | Upgrade
|
| Free Cash Flow Per Share | -0.43 | -0.49 | -0.23 | -0.31 | -0.33 | -0.26 | Upgrade
|
| Cash Interest Paid | 1.76 | 1.76 | 1.64 | 0.78 | 0.5 | 0.43 | Upgrade
|
| Cash Income Tax Paid | 0.06 | 0.06 | 0.04 | 0.2 | 0.26 | 0.33 | Upgrade
|
| Levered Free Cash Flow | -5.38 | -8.5 | 1.03 | -4.39 | -2.36 | -2.64 | Upgrade
|
| Unlevered Free Cash Flow | -3.89 | -7.12 | 2.24 | -3.86 | -2.03 | -2.31 | Upgrade
|
| Change in Working Capital | -4.54 | -4.54 | 5.44 | 0.14 | 3.64 | 1.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.